SL Science (SLBT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.53, -1.29% vs the prior close of $1.55.
- Volume 24.82K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SLBT dips 1.3% to $1.53. Closed at $1.53, -1.29% vs the prior close of $1.55. Day range $1.50–$1.55, opened at $1.54.
SLBT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SLBT dips 1.3% to $1.53
- Closed at $1.53, -1.29% vs the prior close of $1.55. Day range $1.50–$1.55, opened at $1.54.
- Volume was 24.82K shares, 0.3x its 50-day average of 71.94K — lighter than usual.
- Price is -29.7% vs its 50-day average ($2.18) and -76.7% vs its 200-day average ($6.55).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.4% below the 52-week high.
Oct 15, 2026 — SLBT ends flat (+0.0%) to $1.55 on 1.8x normal volume
- Closed at $1.55, +0.00% vs the prior close of $1.55. Day range $1.53–$1.75, opened at $1.55.
- Volume was 130.70K shares, 1.8x its 50-day average of 71.25K — unusually heavy trading.
- Price is -29.5% vs its 50-day average ($2.20) and -76.5% vs its 200-day average ($6.60).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.3% below the 52-week high.
Oct 14, 2026 — SLBT rises 1.3% to $1.55
- Closed at $1.55, +1.31% vs the prior close of $1.53. Day range $1.50–$1.60, opened at $1.50.
- Volume was 30.60K shares, 0.4x its 50-day average of 73.93K — lighter than usual.
- Price is -30.3% vs its 50-day average ($2.22) and -76.7% vs its 200-day average ($6.64).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.3% below the 52-week high.
Oct 13, 2026 — SLBT rises 1.3% to $1.53
- Closed at $1.53, +1.32% vs the prior close of $1.51. Day range $1.49–$1.59, opened at $1.49.
- Volume was 121.20K shares, 1.6x its 50-day average of 75.48K.
- Price is -32.2% vs its 50-day average ($2.26) and -77.1% vs its 200-day average ($6.69).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.4% below the 52-week high.
Oct 12, 2026 — SLBT ends flat (+0.0%) to $1.51
- Closed at $1.51, +0.00% vs the prior close of $1.51. Day range $1.47–$1.53, opened at $1.47.
- Volume was 23.90K shares, 0.3x its 50-day average of 75.32K — lighter than usual.
- Price is -34.1% vs its 50-day average ($2.29) and -77.6% vs its 200-day average ($6.73).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.6% below the 52-week high.
Oct 9, 2026 — SLBT dips 0.7% to $1.51
- Closed at $1.51, -0.66% vs the prior close of $1.52. Day range $1.50–$1.62, opened at $1.50.
- Volume was 25.10K shares, 0.3x its 50-day average of 75.67K — lighter than usual.
- Price is -34.7% vs its 50-day average ($2.31) and -77.7% vs its 200-day average ($6.78).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.6% below the 52-week high.
Oct 8, 2026 — SLBT rises 0.7% to $1.52
- Closed at $1.52, +0.66% vs the prior close of $1.51. Day range $1.50–$1.55, opened at $1.50.
- Volume was 33.40K shares, 0.4x its 50-day average of 76.15K — lighter than usual.
- Price is -35.0% vs its 50-day average ($2.34) and -77.7% vs its 200-day average ($6.82).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.5% below the 52-week high.
Oct 7, 2026 — SLBT dips 0.7% to $1.51, a 52-week low
- Closed at $1.51, -0.66% vs the prior close of $1.52. Day range $1.50–$1.57, opened at $1.51.
- Volume was 68.40K shares, 0.9x its 50-day average of 75.54K.
- Price is -36.0% vs its 50-day average ($2.36) and -78.0% vs its 200-day average ($6.87).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.6% below the 52-week high.
Oct 6, 2026 — SLBT slides 4.4% to $1.52, a 52-week low
- Closed at $1.52, -4.40% vs the prior close of $1.59. Day range $1.52–$1.62, opened at $1.59.
- Volume was 52.20K shares, 0.7x its 50-day average of 77.36K.
- Price is -36.2% vs its 50-day average ($2.38) and -78.0% vs its 200-day average ($6.91).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.5% below the 52-week high.
Oct 5, 2026 — SLBT rises 1.3% to $1.59
- Closed at $1.59, +1.27% vs the prior close of $1.57. Day range $1.56–$1.65, opened at $1.57.
- Volume was 80.70K shares, 1.0x its 50-day average of 81.48K.
- Price is -34.0% vs its 50-day average ($2.41) and -77.2% vs its 200-day average ($6.96).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.0% below the 52-week high.
Oct 2, 2026 — SLBT dips 1.9% to $1.57, 4 down days in a row
- Closed at $1.57, -1.87% vs the prior close of $1.60. Day range $1.57–$1.75, opened at $1.69.
- Volume was 51.60K shares, 0.6x its 50-day average of 83.29K.
- Price is -35.6% vs its 50-day average ($2.44) and -77.6% vs its 200-day average ($7.00).
- 52-week range $1.42–$14.50; today's close sits at 1% of that range, 89.2% below the 52-week high.
- That makes 4 straight losses.
SLBT latest news & SEC filings
Every SEC filing by or about SLBT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Oct 1, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wang Ching-Dong bought 4,545,306 shares at $2,272,653.00 (≈$10.33T) on Sep 29, 2026; now holds 333,832,129
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 12, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Jul 31, 2026 · Form F-1 — F-1 filing
F-1 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade SLBT
- How much it moves: over the last 20 sessions the average daily move was 3.24% (largest 22.9%). That is a volatile stock.
- Liquidity: about 74.92K shares (≈$114.62K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.53 vs a range of $1.42–$14.50 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 24, 2026; 6-K Sep 1, 2026; 6-K Aug 27, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
SLBT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.54 | 1.55 | 1.50 | 1.53 | 24.82K |
| Oct 15, 2026 | 1.55 | 1.75 | 1.53 | 1.55 | 130.70K |
| Oct 14, 2026 | 1.50 | 1.60 | 1.50 | 1.55 | 30.60K |
| Oct 13, 2026 | 1.49 | 1.59 | 1.49 | 1.53 | 121.20K |
| Oct 12, 2026 | 1.47 | 1.53 | 1.47 | 1.51 | 23.90K |
| Oct 9, 2026 | 1.50 | 1.62 | 1.50 | 1.51 | 25.10K |
| Oct 8, 2026 | 1.50 | 1.55 | 1.50 | 1.52 | 33.40K |
| Oct 7, 2026 | 1.51 | 1.57 | 1.50 | 1.51 | 68.40K |
| Oct 6, 2026 | 1.59 | 1.62 | 1.52 | 1.52 | 52.20K |
| Oct 5, 2026 | 1.57 | 1.65 | 1.56 | 1.59 | 80.70K |
| Oct 2, 2026 | 1.69 | 1.75 | 1.57 | 1.57 | 51.60K |
| Oct 1, 2026 | 1.68 | 1.68 | 1.60 | 1.60 | 33.80K |
| Sep 30, 2026 | 1.84 | 1.88 | 1.65 | 1.70 | 27.20K |
| Sep 29, 2026 | 1.90 | 1.92 | 1.83 | 1.83 | 29.80K |
| Sep 28, 2026 | 1.63 | 1.98 | 1.55 | 1.93 | 281.10K |
| Sep 25, 2026 | 1.56 | 1.59 | 1.42 | 1.57 | 284.80K |
| Sep 24, 2026 | 1.66 | 1.70 | 1.50 | 1.56 | 83.50K |
| Sep 23, 2026 | 1.69 | 1.71 | 1.60 | 1.66 | 30.70K |
| Sep 22, 2026 | 1.71 | 1.77 | 1.68 | 1.68 | 28.20K |
| Sep 21, 2026 | 1.71 | 1.83 | 1.66 | 1.72 | 56.60K |
About SL Science
SL Science (SLBT) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in TAIPEI CITY. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2070534.
SLBT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Kwo-Liang Chen | Director | Jun 16, 2026 |
| John Conrad General | Director | Jun 16, 2026 |
| Joseph Levinson | Director | Jun 15, 2026 |
| Mingche Liu | Director | Jun 16, 2026 |
| Ethan Phd Shen | Chief Technology Officer | Jun 16, 2026 |
| Ching-Dong Wang | Chief Executive Officer | Jun 18, 2026 |
| Qian Xu | Director | Jun 17, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Lok Sang Leung | Chief Financial Officer | Jun 16, 2026 |
| Ethan Phd Shen | Chief Technology Officer | Jun 16, 2026 |
| Ching-Dong Wang | Chief Executive Officer | Jun 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SLBT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
SLBT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SLBT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.